Karlan BY - Search Results

1

DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.

Cunningham JM, Winham SJ, Wang C, Weiglt B, Fu Z, Armasu SM, McCauley BM, Brand AH, Chiew YE, Elishaev E, Gourley C, Kennedy CJ, Laslavic A, Lester J, Piskorz A, Sekowska M, Brenton JD, Churchman M, DeFazio A, Drapkin R, Elias KM, Huntsman DG, Karlan BY, Köbel M, Konner J, Lawrenson K, Papaemmanuil E, Bolton KL, Modugno F, Goode EL. Cunningham JM, et al. Among authors: karlan by. Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):132-141. doi: 10.1158/1055-9965.EPI-21-0677. Epub 2021 Oct 25. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 34697060 Free PMC article.

2

BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.

Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY. Baldwin RL, et al. Among authors: karlan by. Cancer Res. 2000 Oct 1;60(19):5329-33. Cancer Res. 2000. PMID: 11034065

3

Differential gene expression between normal and tumor-derived ovarian epithelial cells.

Ismail RS, Baldwin RL, Fang J, Browning D, Karlan BY, Gasson JC, Chang DD. Ismail RS, et al. Among authors: karlan by. Cancer Res. 2000 Dec 1;60(23):6744-9. Cancer Res. 2000. PMID: 11118061

4

Genetic factors in ovarian carcinoma.

Li AJ, Karlan BY. Li AJ, et al. Among authors: karlan by. Curr Oncol Rep. 2001 Jan;3(1):27-32. doi: 10.1007/s11912-001-0039-y. Curr Oncol Rep. 2001. PMID: 11123866 Review.

5

Gene expression in epithelial ovarian carcinoma.

Matei D, Graeber TG, Baldwin RL, Karlan BY, Rao J, Chang DD. Matei D, et al. Among authors: karlan by. Oncogene. 2002 Sep 12;21(41):6289-98. doi: 10.1038/sj.onc.1205785. Oncogene. 2002. PMID: 12214269

6

Improved survival in women with BRCA-associated ovarian carcinoma.

Cass I, Baldwin RL, Varkey T, Moslehi R, Narod SA, Karlan BY. Cass I, et al. Among authors: karlan by. Cancer. 2003 May 1;97(9):2187-95. doi: 10.1002/cncr.11310. Cancer. 2003. PMID: 12712470 Free article.

7

Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States).

Modugno F, Moslehi R, Ness RB, Nelson DB, Belle S, Kant JA, Wheeler JE, Wonderlick A, Fishman D, Karlan B, Risch H, Cramer DW, Dube MP, Narod SA. Modugno F, et al. Cancer Causes Control. 2003 Jun;14(5):439-46. doi: 10.1023/a:1024932427503. Cancer Causes Control. 2003. PMID: 12946038

8

Molecular similarities between primary peritoneal and primary ovarian carcinomas.

Chen LM, Yamada SD, Fu YS, Baldwin RL, Karlan BY. Chen LM, et al. Among authors: karlan by. Int J Gynecol Cancer. 2003 Nov-Dec;13(6):749-55. doi: 10.1111/j.1525-1438.2003.13605.x. Int J Gynecol Cancer. 2003. PMID: 14675310

9

The prognostic significance of thrombocytosis in epithelial ovarian carcinoma.

Li AJ, Madden AC, Cass I, Leuchter RS, Lagasse LD, Karlan BY. Li AJ, et al. Among authors: karlan by. Gynecol Oncol. 2004 Jan;92(1):211-4. doi: 10.1016/j.ygyno.2003.09.002. Gynecol Oncol. 2004. PMID: 14751160

10

Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer.

Byrne JA, Balleine RL, Schoenberg Fejzo M, Mercieca J, Chiew YE, Livnat Y, St Heaps L, Peters GB, Byth K, Karlan BY, Slamon DJ, Harnett P, Defazio A. Byrne JA, et al. Among authors: karlan by. Int J Cancer. 2005 Dec 20;117(6):1049-54. doi: 10.1002/ijc.21250. Int J Cancer. 2005. PMID: 15986428 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

512 results

Search Page